Stockscreener 앱 받기
0.00
100.00%
-0.8441
전일 마감가:
$0.8441
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$10.56M
수익:
$895.50K
순이익/손실:
$-26.30M
주가수익비율:
0.00
EPS:
-65.5728
순현금흐름:
$-23.84M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$2.17
Mainz Biomed N V Stock (MYNZ) Company Profile
Compare MYNZ vs TMO, DHR, IDXX, NTRA, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
0.00 | 10.56M | 895.50K | -26.30M | -23.84M | -65.57 |
TMO
Thermo Fisher Scientific Inc
|
525.91 | 197.88B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.76 | 144.26B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.91 | 44.76B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
264.84 | 38.87B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.60 | 37.13B | 7.23B | 1.41B | 1.09B | 4.979 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-14 | 개시 | Maxim Group | Buy |
| 2024-11-25 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | 개시 | H.C. Wainwright | Buy |
Mainz Biomed N V 주식(MYNZ)의 최신 뉴스
Mainz Biomed (MYNZ) 10K Form and Latest SEC Filings 2026 - MarketBeat
Mainz Biomed NV (MYNZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mainz Biomed (QUCY) Q4 2023 Earnings: EPS Surpasses Estimates as Company Advances Clinical ProgramsAnalyst Consensus Shift - dars.gov.et
Mainz Biomed N V Ord Shs (QUCY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mainz Biomed NV (MYNZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mainz Biomed NV (MYNZ) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mainz Biomed NV (MYNZ) Institutional Confidence - TradingKey
Mainz Biomed NV (MYNZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Valuation: PE, PB & Fair Value Analysis - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Institutional Confidence - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mainz Biomed NV (MYNZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mainz Biomed NV (MYNZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mainz Biomed N V Ord Shs (QUCY) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mainz Biomed NV (MYNZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mainz Biomed BV (NASDAQ: MYNZ) Share Price, MYNZ Stock News, MYNZ Share Price & Updates - Kalkine
Mainz Biomed Q4 2023 Earnings: EPS Beats Estimates Despite No Reported RevenueProfit Inflection Point - newsline.com
Mainz Biomed Q4 2023 Earnings: EPS Beats Expectations Amid Operational ChallengesProfit Guidance Range - newsline.com
[8-K] Quantum Cyber N.V. Reports Material Event - Stock Titan
Mainz Biomed (QUCY) Q4 2023 Earnings: Narrowed Loss Beats Estimates, Stock RalliesNegative Surprise Momentum - newsline.com
Mainz Biomed Q4 2023 Earnings: EPS Beat Amid Revenue Uncertainty, Stock Declines 14%Earnings Surprise Report - newsline.com
Quantum Cyber (NASDAQ: MYNZ) restores Nasdaq minimum bid rule compliance - Stock Titan
QUCYQuantum Cyber NV Stock Price and Quote - Finviz
Director Ben-Tzvi Avraham granted 137,141 Quantum Cyber (MYNZ) shares - Stock Titan
Quantum Cyber (Nasdaq: QUCY) raises $15M and wipes out all debt - Stock Titan
Mainz Biomed (QUCY) Slides 6.5% as Stock Tests Key Support ZoneBreakaway Gap - The Legal Advocate
Mainz Biomed N.V. Ordinary Shares Q4 2023 Earnings: EPS Beat Estimate Despite Absence of Revenue, Stock DeclinesEnergy Earnings Report - Newser
From Cancer Tests to Combat Drones: Mainz Biomed's Radical Reinvention Nears a Key Vote - AD HOC NEWS
Mainz Biomed’s Big Pivot: New Name, New Risks, Same Volatility - Finimize
Quantum Cyber's Patent Salvo Drives Stock Rally Amid Insider Share Awards and Cash Concerns - AD HOC NEWS
Guido Baechler files Form 144 to sell 200,000 MYNZ shares (MYNZ) - Stock Titan
Quantum Cyber N.V. and Other Players Eye Potential CHIPS Act Funding From Trump Administration - The Globe and Mail
Quantum Cyber (QUCY) director files Form 3 reporting zero ordinary shares - Stock Titan
Quantum Cyber (NASDAQ: MYNZ) director awarded 137,141 ordinary shares in Form 4 filing - Stock Titan
QUCY Stock Price and Chart — NASDAQ:QUCY - TradingView
Quantum Cyber forms US defense subsidiary for drone programs - MSN
QUCY Stock Price, Quote & Chart | QUANTUM CYBER NV (NASDAQ:QUCY) - ChartMill
[144] Quantum Cyber N.V. SEC Filing - Stock Titan
Quantum Cyber (MYNZ) inks exclusive IP license with $5M cash and shares - Stock Titan
Mainz Biomed N.v. Live Share Prices and Trades. QUCY.US Live Streaming Share Prices. - London South East
[10-Q] Quantum Cyber N.V. Quarterly Earnings Report - Stock Titan
Quantum Cyber site spotlights drones as Trump administration seeks $55B - Stock Titan
Quantum Cyber N.V. (QUCY-Q) Stock Price and News - The Globe and Mail
3 Penny Stocks to Watch Now, 5/14/26 - TipRanks
Quantum Cyber Stock Surges As Drone Deal And Ex-VA Chief Put Defense Pivot In Focus - TechStock²
Quantum Cyber appoints former VA acting secretary to board - Investing.com India
Mainz Biomed Stock Surges 315% as QUCY Hits $1.34 on Massive Volume - Meyka
Mainz Biomed N V (MYNZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.66%
자본화:
|
볼륨(24시간):